Somatic NRF2 mutations were most frequently found in lung squamous cell carcinoma (LUSC), followed by esophageal carcinoma (ESCA) and uterine corpus endometrial carcinoma (UCEC) cancers (Fig. 2b). This evidence concerns the gene NFE2L2 and uterine corpus endometrial carcinoma.